Jingchao Bai

Statistics

Publications

Citations

170

H-Index

Active since

2013

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Karolinska Institutet

Karolinska University Hospital

Institute of Hematology & Blood Diseases Hospital

Jingchao Bai is an author at Tianjin Medical University Cancer Institute and Hospital specializing in oncology, molecular oncology, and cancer genetics.

ORCID

Publications per year

2013–2018

Publications

Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer

Yunhui Hu, Ernesto Yagüe, Jing Zhao et al. · Cancer Letters · 2018 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17

The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo

Feng Yu, Jing Zhao, Yunhui Hu et al. · Oncology Reports · 2016 · 28 citations

Medicine, Oncology, Pharmacology +12

Epidermal growth factor receptor and <scp>AKT</scp>1 gene copy numbers by multi‐gene fluorescence <i>in situ</i> hybridization impact on prognosis in breast cancer

Jiao Li, Wei Su, Sheng Zhang et al. · Cancer Science · 2015 · 19 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Multi-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients

Chunyan Li, Jingchao Bai, Xiaomeng Hao et al. · Cell Cycle · 2014 · 17 citations · Full text

Life Sciences, Genetics, Oncology +16

QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancer

Sheng Zhang, Yingbo Shao, Guofang Hou et al. · Tumor Biology · 2013 · 12 citations

Life Sciences, Molecular Genetics, Oncology +17

1–5 of 6